US EditionAstrana Health, Inc. to Participate in Upcoming Investor Conferences
Astrana Health executives will engage institutional investors through presentations, fireside chats, and meetings to enhance visibility and discuss company strategy and value drivers.
- On 03/04/2026, LCI Industries announced participation in three upcoming investor conferences, according to its press release.
- Lillian Etzkorn, Chief Financial Officer, will host investor meetings throughout the day at all three events as LCI Industries engages investors in recreation and transportation markets.
- Loop Capital Markets will meet on March 9th for its 7th Annual Investor Conference, followed by the Wolfe Research Small Group Conference on March 17th and the 38th Annual Roth Conference on March 23rd.
- Jason Lippert will participate at the Roth Conference, and investors can contact Lillian D. Etzkorn, CFO, at 535-1125.
- LCI Industries will participate in investor conferences on March 9, March 17, and March 23, 2026, with details published in the BusinessWire source and IR materials.
33 Articles
33 Articles
Montana Standard
Astrana Health, Inc. to Participate in Upcoming Investor Conferences
ALHAMBRA, Calif., March 3, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today…
ivpressonline.com
Inhibrx Announces Participation in Upcoming Scientific Conference
SAN DIEGO, March 2, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, today announced it will be presenting at the following upcoming scientific conference:
Hastings Tribune
Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences:
Valneva to Participate in Upcoming Investor Conferences
Lyon (France), March 2, 2026 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced its senior management will present and meet with investors at upcoming investor conferences in the United States and Europe. CEO Thomas Lingelbach and CFO Peter Buhler will discuss the Company's key value drivers and upcoming catalysts, including the topline Phase 3 data readout for VLA15, the Company's Lyme disease vaccine candidate,…
Coverage Details
Bias Distribution
- 83% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
